Innovative RNA Technologies SomaGenics specializes in small RNA technologies including RNAi-based therapeutics and diagnostic tools, presenting opportunities to collaborate with biotech or pharma companies seeking advanced RNA-based solutions.
Recent Product Launch The launch of RealSeq biofluids, a highly sensitive NGS library kit, indicates capabilities in genetic sequencing that can meet increasing demand for liquid biopsy and biomarker detection services across clinical and research markets.
Growing Market Presence Despite a small team, SomaGenics operates in a rapidly expanding biotech industry with potential for strategic partnerships focused on small RNA diagnostics, therapeutics, and personalized medicine.
Funding and Revenue Potential With moderate funding and revenue between 1 to 10 million dollars, there are growth opportunities through investment in R&D, expanding product lines, and entering new markets with innovative RNA solutions.
Strategic Collaborations SomaGenics’ focus on cutting-edge RNA technologies and sequencing tools positions it well for partnerships with larger biotech firms, research institutions, and healthcare companies aiming to develop next-generation RNA diagnostics and therapeutics.
$100M$250M
$25M$50M
$250M$500M
$1B$10BSomaGenics, Inc. uses 8 technology products and services including Webpack, Chart.js, jQuery, and more. Explore SomaGenics, Inc.'s tech stack below.
| SomaGenics, Inc. Email Formats | Percentage |
| FLast@somagenics.com | 50% |
| FLast@somagenics.com | 50% |
Biotechnology ResearchCalifornia, United States2-10 Employees
SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection (NGS, quantitative PCR) of small or fragmented RNA, including microRNA.
Company Overview
Funding & FinancialsSomaGenics, Inc. has raised a total of $1.8M of funding over 1 rounds. Their latest funding round was raised on Oct 04, 2016 in the amount of $1.8M.
SomaGenics, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsSomaGenics, Inc. has raised a total of $1.8M of funding over 1 rounds. Their latest funding round was raised on Oct 04, 2016 in the amount of $1.8M.
SomaGenics, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com